Syndax Pharmaceuticals (SNDX) Net Margin (2015 - 2026)
Syndax Pharmaceuticals' (SNDX) quarterly Net Margin came in at 65.43% in Q1 2026, up 35655.0% year-on-year from N/an in Q1 2025, and up 22.76% quarter-over-quarter from 84.71% in Q4 2025.
Syndax Pharmaceuticals (SNDX) Net Margin (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Net Margin history runs 10 years deep, the most recent figure standing at 65.43% for Q1 2026.
- On a quarterly basis, Net Margin rose 35655.0% year-over-year to 65.43% in Q1 2026; TTM through Mar 2026 was 108.94%, a 66403.0% increase from a year earlier, with the FY2025 full-year figure at 178.26%, up 223821.0% from the prior year.
- Net Margin climbed to 65.43% in Q1 2026 per SNDX's latest filing, from 84.71% in the prior quarter.
- Across five years, Net Margin topped out at 65.43% in Q1 2026 and bottomed at 2145.54% in Q2 2024.
- The 3-year median for Net Margin is 310.77% (2025), against an average of 618.5%.
- Across the five-year window, Net Margin soared 194599 bps in 2025 and jumped 35655 bps in 2026, its largest moves.
- Year by year, Net Margin stood at 1225.7% in 2024, then soared by 93 bps to 84.71% in 2025, then rose by 23 bps to 65.43% in 2026.
- Per Business Quant, the three latest SNDX Net Margin figures stand at 65.43% (Q1 2026), 84.71% (Q4 2025), and 131.8% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | -65.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.43% |
| Dec 31, 2025 | -84.71% |
| Sep 30, 2025 | -131.80% |
| Jun 30, 2025 | -199.55% |
| Mar 31, 2025 | -421.98% |
| Dec 31, 2024 | -1,225.70% |
| Sep 30, 2024 | -673.26% |
| Jun 30, 2024 | -2,145.54% |
| Dec 31, 2021 | 75.32% |
| Sep 30, 2021 | -166.45% |
| Jun 30, 2021 | -6,058.05% |
| Mar 31, 2021 | -7,327.97% |
| Dec 31, 2020 | -5,329.47% |
| Sep 30, 2020 | -5,359.10% |
| Jun 30, 2020 | -4,532.72% |
| Mar 31, 2020 | -4,089.97% |
| Dec 31, 2019 | -3,375.26% |
| Sep 30, 2019 | -3,789.45% |
| Jun 30, 2019 | -4,392.35% |
| Mar 31, 2019 | -3,936.15% |